{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005677","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.629581+00:00","generated_at":"2026-05-27T00:13:48.172517+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"INBS reports prelim Q2 revenue ~$0.61M; gross margin up to 38.5%; FDA 510(k) submitted for U.S. market entry in 2025","bullets":["Preliminary Q2 FY2025 revenue ~$0.61M; 6-month revenue ~$1.48M; gross profit margin improved to 38.5% from 27.7%.","Fiscal year 2024 revenues grew 148% YoY; over 400 accounts in 19 countries with customer employee base ~1.4M.","Submitted 510(k) pre-market notification to FDA in Dec 2024; on track for U.S. market entry in 2025.","PK study showed fingerprint sweat correlates with blood at 95% confidence; Method Comparison Study showed ~94% accuracy.","Gross profit up 32.6% to $0.57M for six months; strategic focus on higher-margin cartridge sales driving margin expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005677","json":"https://secwatch.observer/filing/0001493152-25-005677.json","markdown":"https://secwatch.observer/filing/0001493152-25-005677.md","text":"https://secwatch.observer/filing/0001493152-25-005677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225005677/0001493152-25-005677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225005677/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:13:48.172517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}